India  

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Video Credit: Wibbitz Top Stories - Duration: 01:31s - Published
Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter , Profits Blast Past, 2022 Forecast.

ABC reports that Pfizer's COVID-19 vaccine and treatment sales helped propel the pharmaceuticals company beyond Wall Street's first quarter expectations.

.

Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter.

.

Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter.

.

The vaccine has remained Pfizer's top selling product for almost the last year.

.

The drugmaker's pill treatment Paxloid reportedly added an additional $1.5 billion to the company's sales.

.

ABC reports that Pfizer's, profits grew 61% , in the first quarter.

.

On May 3, the company posted a net income of $7.86 billion and first quarter adjusted earnings of $1.62 per share.

.

The results easily exceeded the $1.49 increase predicted by industry analysts.

.

Compared to the same time last year, the company's revenue skyrocketed 77% , to reach $25.66 billion.

.

According to ABC, the drugmaker expects the company's total revenue in 2022 to reach between $98 billion and $102 billion.

.

Pfizer's COVID vaccine launched late in 2020 and quickly became the company's top selling product by the second quarter of 2021.

In December of 2021, Pfizer's stock reached an all-time high of $61.71 per share.


You Might Like


💡 newsR Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants [Video]

FDA Calls for Fall COVID Boosters To Target Omicron Subvariants

FDA Calls for Fall COVID Boosters , To Target Omicron Subvariants. NBC News reports that on June 30, the Food and Drug Administration asked vaccine makers to modify upcoming booster shots to target subvariants of Omicron. The Omicron subvariants the agency wishes to target are BA.4 and BA.5. Officials have called on vaccine makers Pfizer-BioNTech and Moderna to produce bivalent vaccines, . which are intended to target the original strain of COVID-19 as well as its subvariants. As we move into the fall and winter, it is critical that we have safe and effective vaccine boosters that can provide protection... , Dr. Peter Marks, FDA, via NBC News. ... against circulating and emerging variants to prevent the most severe consequences of COVID-19. , Dr. Peter Marks, FDA, via NBC News. As of the week ending June 25, Omicron subvariants BA.4 and BA.5 were responsible for 52% of all new cases of COVID-19. Per the Centers for Disease Control and Prevention, BA.1, the first variant of Omicron, caused 0% of new cases. Pfizer and Moderna have thus far altered vaccines to target the original strain of COVID-19 and BA.1. which increased the immune response to earlier iterations, though both have waned in their efficacy against BA.4 and BA.5

Credit: Wibbitz Top Stories    Duration: 01:30Published
Elmo Gets Vaccinated Against COVID [Video]

Elmo Gets Vaccinated Against COVID

Elmo Gets Vaccinated , Against COVID. Earlier this month, Moderna and Pfizer/BioNTech vaccines were given emergency use authorization for children as young as six months old. The CDC also signed off on the shots for kids under 5. On June 28, 'Sesame Street' issued a public service announcement to spread the word. Elmo's dad, Louie, addressed getting his son vaccinated. Elmo's dad, Louie, addressed getting his son vaccinated. Was it safe? Was it the right decision?’ I talked to our pediatrician so I could make the right choice. I learned that Elmo getting vaccinated is the best way to keep himself, our friends, neighbors and everyone else healthy and enjoying the things they love, Louie, Elmo's dad, via 'Sesame Street'. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. According to a Kaiser Family Foundation Vaccine Monitor survey conducted in April, 38% of parents wanted to "wait and see" before vaccinating their young kids. Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, issued a statement about the PSA. We hope that Louie and Elmo will inspire parents and caregivers across the country to speak with their healthcare providers and seek out information to learn about how the COVID-19 vaccines can keep young children and their families healthy, Jeanette Betancourt, senior vice president of U.S. social impact at Sesame Workshop, via CNN. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated. The CDC reports that as of June 22, 30% of kids between the ages of 5 and 11 and 60% between the ages of 12 and 17 were fully vaccinated

Credit: Wibbitz Top Stories    Duration: 01:31Published
Pfizer Says Updated COVID-19 Shot Effective Against Omicron [Video]

Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Pfizer Says Updated COVID-19 Shot , Effective Against Omicron. NBC News reports Pfizer announced on June 25 that its updated coronavirus vaccine better targets the omicron variant. Experts say while current vaccines offer ample protection against new variants, . their effectiveness has waned in the age of omicron. The Food and Drug Administration has considered ordering altered vaccines, . hoping a modified recipe could offer more protection when coronavirus surges again this fall and winter. Pfizer says after studying over 1,200 adults who had received three vaccine doses. officials say each of their vaccines showed a substantial increase in omicron-resistant antibodies. Based on these data, we believe we have two very strong omicron- adapted candidates. , statement from Pfizer CEO Albert Bourla, via NBC News. Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies. almost 1.5 times higher than the company's initial dose

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]

FDA Panel Endorses COVID Vaccines for Children Under 5

FDA Panel , Endorses COVID Vaccines, for Children Under 5. On June 15, an advisory panel to the United States Food and Drug Administration voted to recommend two COVID-19 vaccines for kids ages 5 and under. Yahoo reports that both Pfizer/BioNTech and Moderna were under review by the panel. . The unanimous FDA panel vote is the first step in what is predicted to be a quick authorization process. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. Yahoo reports that parents now have two options for how to vaccinate their children. Pfizer's vaccine for kids is delivered in three, three-microgram doses, while Moderna's vaccine is delivered in two shots of a 25-microgram dose. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. The committee’s support today is imperative to providing a critical tool for pediatricians, parents, and caregivers who eagerly await an option for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Both companies are now awaiting approval from the FDA and the CDC which will hold an advisory committee meeting on the topic over the weekend.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval [Video]

Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval . Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. The three-dose vaccine is for children between the ages of six months and five years. Pfizer released a statement detailing the application. Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News. ... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News. ... for children 6 months through 4 years of age (also referred to as 6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News. Pfizer reported an 80 percent effectiveness rate in children in May. The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application. We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News. ... and while the FDA cannot predict how long its evaluation of the data and information will take, , FDA Statement, via ABC News. ... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News. According to a poll conducted by the Kaiser Family Foundation in April of this year. ... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved. 27 percent of parents stated that they will "definitely not" vaccinate their children against COVID

Credit: Wibbitz Top Stories    Duration: 01:31Published

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Covid-19 Update: India reports 13,086 fresh Covid cases in 24 hours | OneIndia News *News [Video]

Covid-19 Update: India reports 13,086 fresh Covid cases in 24 hours | OneIndia News *News

In a slight relief to many, India recorded a major dip in Covid-19 cases after reporting more than 16,000 cases for the past few days. 13,086 fresh covid cases were added to the total tally of Covid-19 infections in the country on Tuesday. 19 covid related casualties were recorded on Monday. This was a major dip from 16,135 infections logged on Monday. #CovidUpdate #Covid19Cases #Live

Credit: Oneindia    Duration: 01:33Published
Karlovy Vary film festival returns for its 56th edition after two years marred by COVID-19 [Video]

Karlovy Vary film festival returns for its 56th edition after two years marred by COVID-19

The historic festival, considered amongst the best in Europe, is back for its 56th edition after two years affected by the COVID-19 pandemic.

Credit: euronews (in English)    Duration: 01:48Published

Covid 4th wave: India reports 16,103 new cases and 31 deaths in 24 hours

Covid in India: The active cases now increased to 1,11,711, as per the Union Health Ministry data updated on Sunday.
DNA

Centre grants financial aid to families of 35 journalists who died of Covid

The committee has approved total assistance of Rs 1.81 Cr during the meeting.
DNA

Pfizer–BioNTech COVID-19 vaccine Pfizer–BioNTech COVID-19 vaccine Type of vaccine for humans

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA [Video]

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA. NBC News reports on May 17, the Food and Drug Administration (FDA)... … announced it had authorized Pfizer-BioNTech's coronavirus booster dose for 5 to 11 year olds. The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series. Per NBC News, Pfizer's booster shot for 5 to 11 year olds is 10 micrograms ... . ... a third of the dosage given to citizens 12 and older. Following the FDA's ruling, it is now up to the Centers for Disease Control and Prevention (CDC) to recommend how to implement boosters for the age group. CDC data shows less than one third of 5 to 11 year olds in the United States have recieved the primary series of a COVID-19 vaccine. Experts say booster shots offer better protection against the omicron strain and its associated subvariants. The CDC's Advisory Committee on Immunization Practices will reportedly discuss booster shots on May 19. Dr. Rochelle Walensky, the Director of the CDC, should have her final recommendation following the committee's discussion

Credit: Wibbitz Top Stories    Duration: 01:30Published